Akshitkumar M Mistry1, Nishit Mummareddy1, Sanjana Salwi2, Larry T Davis3, Rebecca A Ihrie1,4. 1. Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN, United States. 2. School of Medicine, Vanderbilt University, Nashville, TN, United States. 3. Department of Radiology, Vanderbilt University Medical Center, Nashville, TN, United States. 4. Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, United States.
Abstract
OBJECTIVE: To determine the relationship between survival and glioblastoma distance from the ventricular-subventricular neural stem cell niche (VSVZ). METHODS: 502 pre-operative gadolinium-enhanced, T1-weighted MRIs with glioblastoma retrieved from an institutional dataset (n = 252) and The Cancer Imaging Atlas (n=250) were independently reviewed. The shortest distance from the tumor contrast enhancement to the nearest lateral ventricular wall, the location of the VSVZ, was measured (GBM-VSVZDist). The relationship of GBM-VSVZDist with the proportion of glioblastomas at each distance point and overall survival was explored with a Pearson's correlation and Cox regression model, respectively, adjusting for the well-established glioblastoma prognosticators. RESULTS: 244/502 glioblastomas had VSVZ contact. The proportion of non-VSVZ-contacting glioblastomas correlated inversely with GBM-VSVZDist (partial Pearson's correlation adjusted for tumor volume R=-0.79, p=7.11x10-7). A fit of the Cox regression model adjusted for age at diagnosis, Karnofsky performance status score, post-operative treatment with temozolomide and/or radiotherapy, IDH1/2 mutation status, MGMT promoter methylation status, tumor volume, and extent of resection demonstrated a significantly decreased overall survival only when glioblastoma contacted the VSVZ. Overall survival did not correlate with GBM-VSVZDist. CONCLUSIONS: In the two independent cohorts analyzed, glioblastomas at diagnosis were found in close proximity or in contact with the VSVZ with a proportion that decreased linearly with GBM-VSVZDist. Patient survival was only influenced by the presence or absence of a gadolinium-enhanced glioblastoma contact with the VSVZ. These results may guide analyses to test differential effectiveness of VSVZ radiation in VSVZ-contacting and non-contacting glioblastomas and/or inform patient selection criteria in clinical trials of glioblastoma radiation.
OBJECTIVE: To determine the relationship between survival and glioblastoma distance from the ventricular-subventricular neural stem cell niche (VSVZ). METHODS: 502 pre-operative gadolinium-enhanced, T1-weighted MRIs with glioblastoma retrieved from an institutional dataset (n = 252) and The Cancer Imaging Atlas (n=250) were independently reviewed. The shortest distance from the tumor contrast enhancement to the nearest lateral ventricular wall, the location of the VSVZ, was measured (GBM-VSVZDist). The relationship of GBM-VSVZDist with the proportion of glioblastomas at each distance point and overall survival was explored with a Pearson's correlation and Cox regression model, respectively, adjusting for the well-established glioblastoma prognosticators. RESULTS: 244/502 glioblastomas had VSVZ contact. The proportion of non-VSVZ-contacting glioblastomas correlated inversely with GBM-VSVZDist (partial Pearson's correlation adjusted for tumor volume R=-0.79, p=7.11x10-7). A fit of the Cox regression model adjusted for age at diagnosis, Karnofsky performance status score, post-operative treatment with temozolomide and/or radiotherapy, IDH1/2 mutation status, MGMT promoter methylation status, tumor volume, and extent of resection demonstrated a significantly decreased overall survival only when glioblastoma contacted the VSVZ. Overall survival did not correlate with GBM-VSVZDist. CONCLUSIONS: In the two independent cohorts analyzed, glioblastomas at diagnosis were found in close proximity or in contact with the VSVZ with a proportion that decreased linearly with GBM-VSVZDist. Patient survival was only influenced by the presence or absence of a gadolinium-enhanced glioblastoma contact with the VSVZ. These results may guide analyses to test differential effectiveness of VSVZ radiation in VSVZ-contacting and non-contacting glioblastomas and/or inform patient selection criteria in clinical trials of glioblastoma radiation.
Authors: Tyler C Steed; Jeffrey M Treiber; Birra Taha; H Billur Engin; Hannah Carter; Kunal S Patel; Anders M Dale; Bob S Carter; Clark C Chen Journal: J Neurooncol Date: 2020-06-15 Impact factor: 4.130
Authors: Akshitkumar M Mistry; Michael C Dewan; Gabrielle A White-Dzuro; Philip R Brinson; Kyle D Weaver; Reid C Thompson; Rebecca A Ihrie; Lola B Chambless Journal: J Neurooncol Date: 2017-01-10 Impact factor: 4.130
Authors: Akshitkumar M Mistry; Andrew T Hale; Lola B Chambless; Kyle D Weaver; Reid C Thompson; Rebecca A Ihrie Journal: J Neurooncol Date: 2016-09-19 Impact factor: 4.130
Authors: Kmp Batista; Bal Costa; Ica Pablo; I F Vega; Jcg Morales; A V Alvarez; A Meilán; A Astudillo; K Y Alvarez Journal: Folia Neuropathol Date: 2016 Impact factor: 2.038
Authors: Mark R Gilbert; James J Dignam; Terri S Armstrong; Jeffrey S Wefel; Deborah T Blumenthal; Michael A Vogelbaum; Howard Colman; Arnab Chakravarti; Stephanie Pugh; Minhee Won; Robert Jeraj; Paul D Brown; Kurt A Jaeckle; David Schiff; Volker W Stieber; David G Brachman; Maria Werner-Wasik; Ivo W Tremont-Lukats; Erik P Sulman; Kenneth D Aldape; Walter J Curran; Minesh P Mehta Journal: N Engl J Med Date: 2014-02-20 Impact factor: 91.245
Authors: T T Liu; A S Achrol; L A Mitchell; W A Du; J J Loya; S A Rodriguez; A Feroze; E M Westbroek; K W Yeom; J M Stuart; S D Chang; G R Harsh; D L Rubin Journal: AJNR Am J Neuroradiol Date: 2016-01-07 Impact factor: 3.825
Authors: Akshitkumar M Mistry; David J Wooten; L Taylor Davis; Bret C Mobley; Vito Quaranta; Rebecca A Ihrie Journal: Sci Rep Date: 2019-02-12 Impact factor: 4.379
Authors: Sharon Berendsen; Emma van Bodegraven; Tatjana Seute; Wim G M Spliet; Marjolein Geurts; Jeroen Hendrikse; Laurent Schoysman; Willemijn B Huiszoon; Meri Varkila; Soufyan Rouss; Erica H Bell; Jérôme Kroonen; Arnab Chakravarti; Vincent Bours; Tom J Snijders; Pierre A Robe Journal: PLoS One Date: 2019-10-11 Impact factor: 3.240
Authors: Yi Lao; Dan Ruan; April Vassantachart; Zhaoyang Fan; Jason C Ye; Eric L Chang; Robert Chin; Tania Kaprealian; Gabriel Zada; Mark S Shiroishi; Ke Sheng; Wensha Yang Journal: Int J Radiat Oncol Biol Phys Date: 2021-12-26 Impact factor: 7.038